Exploratory trial of clinical effects by ingestion of beta-glucan-containing test-food - Exploratory trial of clinical effects by ingestion of beta-glucan-containing test-food

CPCC Company Limited0 sites16 target enrollmentJune 28, 2021

Overview

No summary available.

Registry

who.int

Start Date

June 28, 2021

End Date

August 3, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

Male

Sponsor

CPCC Company Limited

•(1\) Subjects with their body temperature of not less than 37\.5 degree centigrade at the first coming to clinic. (2\) Subjects with any symptoms just like the common cold within two weeks before the first coming to clinic. (3\) Subjects with some kind of medical treatment. (4\) Subjects who have regularly took in health\-specific / functional / health foods, containing a lot of beta\-glucan, over three times a week. (5\) Subjects who have regularly took in immunostimulation foods, over three times a week. (6\) Subjects with previous medical history of drug and/or food allergy. (7\) Subjects who are now under the other clinical tests with some kind of medicines/foods, or participated those tests within four weeks after the current trial. (8\) Subjects who donated over 200 mL of their whole blood and/or blood components within a month to the current trial. (9\) Subjects who donated over 400 mL of their whole blood within the last three months to the current trial. (10\) Subjects who are going to be collected over 1200 mL in total of their blood within the last twelve months, after adding the planned sampling blood amounts in this trial. (11\) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.